6505--Trastuzumab and Biosimilars

Active

Contract Opportunity

Presolicitation Notice

Presolicitation Notice

Page 3 of 3
Presolicitation Notice
*=Required Field
Presolicitation Notice

Page 1 of 3

SUBJECT*
Trastuzumab and Biosimilars

GENERAL INFORMATION
CONTRACTING OFFICE S ZIP CODE*
60141
SOLICITATION NUMBER*
36E79725R0038
RESPONSE DATE/TIME/ZONE
06-04-2025 2:30 PM CENTRAL TIME, CHICAGO, USA
ARCHIVE
99 DAYS AFTER THE RESPONSE DATE
SET-ASIDE

PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412
PLACE OF PERFORMANCE



POSTAL CODE

COUNTRY
CONTACT INFORMATION
CONTRACTING OFFICE ADDRESS
Department of Veteran Affairs
OPAL/ National Acquisition Center
Building 37
1st Avenue, One block North of Cermak

POINT OF CONTACT*

Contract Specialist
Anthony Di Crescenzo
anthony.dicrescenzo@va.gov
708-786-4984

ADDITIONAL INFORMATION
AGENCY S URL

URL DESCRIPTION

AGENCY CONTACT S EMAIL ADDRESS
anthony.dicrescenzo@va.gov
EMAIL DESCRIPTION
Agency POC email

DESCRIPTION
PRE-SOLICITATION NOTICE:Â The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0038 for an unrestricted procurement for Trastuzumab and Biosimilars, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).Â
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.Â
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror.
Solicitation # 36E79725R0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 21, 2025, with a tentative closing date of June 4, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Anthony Di Crescenzo. Questions can be e-mailed to anthony.dicrescenzo@va.gov. Â Â
The estimated annual requirements are as follows:Â
REQUIREMENT DESCRIPTIONÂ
ITEMÂ
DESCRIPTIONÂ
Package Size
(mg per Vial)
TOTAL EST. ANNUAL USAGE (VIALS)
1Â
TRASTUZUMAB 150MG/VIL INJ
150
10,297
2Â
TRASTUZUMAB 420MG/VIL INJ
420
1,426

*Proposed biosimilar products must be biological products licensed by the FDA under 42 U.S.C § 262 and must meet all biosimilar criteria described in 42 U.S.C. § 262. Additionally, Biosimilars Products must be FDA approved as a biologic medication that is compared to the innovator (the original biologic) and listed as a biosimilar to the innovator in the FDA Purple Book (https://purplebooksearch.fda.gov/).

Attachments/Links